The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs
Elena Andreucci, Alessio Biagioni, Sara Peri, Giampaolo Versienti, Fabio Cianchi, Fabio Staderini, Lorenzo Antonuzzo, Claudiu T. Supuran, Erika Olivo, Elisa Pasqualini, Luca Messerini, Daniela Massi, Matteo Lulli, Jessica Ruzzolini, Silvia Peppicelli, Francesca Bianchini, Nicola Schiavone, Lido Calorini, Lucia Magnelli, Laura Papucci
Topics & Concepts
DocetaxelOxaliplatinCancerCisplatinTaxaneMedicinePaclitaxelCancer researchCancer cellPharmacologyChemotherapyOncologyInternal medicineDrug resistanceColorectal cancerBiologyBreast cancerMicrobiologyEnzyme function and inhibitionCoagulation, Bradykinin, Polyphosphates, and AngioedemaSynthesis and Catalytic Reactions